Otonomy Board Approves Plan to Liquidate, Dissolve

Dow Jones
2022/12/20

By Denny Jacob

 

Otonomy Inc. on Monday said its board approved and adopted a plan to liquidate and dissolve its operations.

The plan, which is subject to shareholder approval, includes distributing remaining cash to shareholders after operations wind down, as well as proceeds from the sale of any pipeline assets, which it says is currently in discussions.

The biopharmaceutical company said it terminated all its employees, including officers, as part of the planned dissolution, effective last Thursday. David Weber continues to serve on the board and Paul Cayer continues to serve on a consulting basis as chief financial and business officer, as well as being appointed president. Otonomy said it expects to incur charges around $5 million for severance and other employee-termination related costs in the fourth quarter.

Otonomy said its board approved its plan last Tuesday. It intends to call a special shareholder meeting in the first quarter to seek approval for the plan and said it will file proxy materials with the Securities and Exchange Commission as soon as practicable.

 

Write to Denny Jacob at denny.jacob@wsj.com

 

(END) Dow Jones Newswires

December 19, 2022 17:21 ET (22:21 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10